[1]
2018. Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S19. DOI:https://doi.org/10.25251/skin.2.supp.19.